Heterocyclic Building Blocks

Sulfur-Containing Heterocycles

Thienopyridine Derivatives Thiophene Derivatives

Indole Derivatives

Spiro cyclic Heterocycles

Bridged Bicyclic Heterocycles

Pidine Derivatives

Pyridine Derivatives

Isoquinoline Derivatives

Fused Bicyclic Heterocycles

Pyridine Derivatives

Pyrazole Derivatives

Sulfur-Containing Heterocycles

Thiophene Derivatives

Fused Bicyclic Heterocycles

Azepine Derivatives

Benzazepines

Pyridazine Derivatives

Fused Bicyclic Heterocycles

Pyrazolo-pyrimidine Derivatives Isoquinoline Derivatives Pyrrolopyrimidine Derivatives Pyrrolopyridine Derivatives Imidazopyridine Derivatives Pyrazolo-pyridine Derivatives

Sulfur-Containing Heterocycles

Spiro cyclic Heterocycles

Coumarin Derivatives

Pyrrole Derivatives

Benzoxaborole Derivatives

Pyridone Derivatives

Oncology Drug Intermediates

Enzyme Inhibitor Intermediates

Kinase Inhibitors

En Inhibitor Intermediates

Kinase Inhibitors

Alkylating Agents

Cytotoxic Natural Products

Neurological Intermediates

Anticonvulsants

Cardiovascular Intermediates

Cardiac Glycosides

Vasodilator Intermediates

Angiotensin II Receptor Blockers

Calcium Channel Blockers

Organic Synthesis Intermediates

Nitrile Intermediates

Heterocyclic Building Blocks

Quinoline Derivatives

Aromatic Alcohols

Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Nitro Aromatic Alcohols Nitro Aromatic Alcohols Nitro Aromatic Alcohols Halogenated Aromatic Alcohols

Ketone Intermediates

Antidiabetic Intermediates

Antimalarial Intermediates

Amide Intermediates

Benzamide Derivatives

Enzyme Inhibitor Intermediates

Kinase Inhibitors

Carbonic Anhydrase Inhibitors

Nitro Aromatic Derivatives

Drug Discovery Reagents

Antimalarial Intermediates

Oncology Drug Intermediates

Enzyme Inhibitor Intermediates

Sulfonamide Intermediates

Neurological Research Reagents

Heterocyclic Building Blocks

Antihistamine Intermediates

Phenolic Intermediates

Halogenated Phenols

Aliphatic Carboxylic Acid Derivatives

Malonic Acid Derivatives

Drug Delivery Intermediates

Surface Modification Reagents

REAGENT

(1R)-7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione

98%

CAS:2300966-23-6

Formula:C₁₆H₁₄ClFN₄O₂

MW:348.76 g/mol

฿1,000.00

ข้อมูล

REAGENT

((1R,2S)-2-(3-fluorophenyl)-2-((p-tosyloxy)methyl)cyclopropyl)methyl acetate

99%

CAS:1450904-92-3

Formula:C₂₀H₂₁FO₅S

MW:392.44 g/mol

฿8,550.00

ข้อมูล

REAGENT

(3R,6R)-6-Methylpiperidine-3-carboxylic acid hydrochloride

95%

CAS:2682097-03-4

Formula:C₇H₁₄ClNO₂

MW:179.64 g/mol

฿11,240.00

ข้อมูล

REAGENT

(R)-4-Benzyl-2-(isoquinolin-1-yl)-4,5-dihydrooxazole

97%

CAS:2757083-35-3

Formula:C₁₉H₁₆N₂O

MW:288.34 g/mol

฿8,920.00

ข้อมูล

REAGENT

rel-(3aR,6aR)-Hexahydrocyclopenta[c]pyrrole-3a(1H)-carboxylic acid

98%

CAS:1212067-49-6

Formula:C₈H₁₃NO₂

MW:155.19 g/mol

฿5,030.00

ข้อมูล

REAGENT

(R)-1-(3-(1-Aminoethyl)phenyl)-1,1-difluoro-2-methylpropan-2-ol

95%

CAS:2738393-85-4

Formula:C₁₂H₁₇F₂NO

MW:229.27 g/mol

฿11,540.00

ข้อมูล

REAGENT

(R)-4-(2-((p-Tolyloxy)methyl)pyrrolidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine

97%

CAS:2757697-86-0

Formula:C₁₈H₂₀N₄O

MW:308.38 g/mol

฿8,280.00

ข้อมูล

REAGENT

(R)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid

97%

CAS:1638497-25-2

Formula:C₁₈H₂₁ClN₄O₄

MW:392.84 g/mol

฿13,680.00

ข้อมูล

REAGENT

rel-((3aR,6aR)-Octahydrocyclopenta[c]pyrrol-3a-yl)methanol

95%

CAS:2696257-98-2

Formula:C₈H₁₅NO

MW:141.21 g/mol

฿5,730.00

ข้อมูล

REAGENT

(R)-1-(1H-Benzo[d]imidazol-2-yl)ethanamine dihydrochloride

97%

CAS:2503155-57-3

Formula:C₉H₁₃Cl₂N₃

MW:234.13 g/mol

฿3,940.00

ข้อมูล

ตะกร้า

ไม่มีสินค้า

Subtotal: 0.00

รวมทั้งสิ้น 0.00 THB

ตะกร้า สั่งซื้อ

Researcher Network คุณอยู่ในองค์กรการวิจัยใดๆ หรือไม่? ใช้อีเมลองค์กรของคุณเพื่อตรวจสอบสิทธิ์และข้อกำหนดใบกำกับภาษีขององค์กร ดูรายละเอียด